{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:06:27Z","timestamp":1778504787972,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T00:00:00Z","timestamp":1153094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gender differences in a large population\u2010based cohort of HIV\u20101 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART between January 1996 and December 2003. The outcome measures were the incidence of hyperglycemia, hypercholesterolemia, symptomatic lactic acidosis, treatment\u2010limiting lipodystrophy, and hypersensitivity reaction. Cox proportional hazards models were used to estimate the crude and adjusted hazard ratios of reaching the endpoints for exposures and covariates. Women were younger than men (35\u2009\u00b1\u20099.8 vs. 40\u2009\u00b1\u20098.2 years, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and more frequently from Haiti or Africa (59%), whereas 76% of men were Canadian\u2010born. Type of initial HAART regimen did not differ between women and men. There were no gender differences in the overall incidence of hyperglycemia, hypercholesterolemia, or treatment\u2010limiting lipodystrophy, even after adjusting for age, CD4 cell count, viral load, time since HIV diagnosis, history of AIDS\u2010defining illness and year of HAART initiation. In contrast, women had significantly higher risk of developing lactic acidosis than men (<jats:italic>P<\/jats:italic>\u2009=\u20090.0009). Hypersensitivity reactions were also more frequent in women than men (adjusted hazard ratio\u2009=\u20094.4 (95% CI: 2.1\u20139.3)). Collectively, these data suggest that metabolic toxicities after HAART do not differ by gender but that lactic acidosis and hypersensitivity reactions are more frequent in women than men. J. Med. Virol. 78:1158\u20131163, 2006. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.20676","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T04:28:26Z","timestamp":1153196906000},"page":"1158-1163","source":"Crossref","is-referenced-by-count":15,"title":["Gender and long\u2010term metabolic toxicities from antiretroviral therapy in HIV\u20101 infected persons"],"prefix":"10.1002","volume":"78","author":[{"given":"Mohamed\u2010Rachid","family":"Boulassel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina B.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.79.4.340"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1310\/VHBA-X9FE-YRQR-YVBK"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/317536"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1310\/BRE5-448N-WUPU-JWVL"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00016"},{"key":"e_1_2_1_7_1","first-page":"1322","article-title":"Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group","volume":"6","author":"Cotton DJ","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_1_8_1","first-page":"S4","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"23","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2000","journal-title":"Diabetes Care"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200309010-00008"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450033347109"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00148-6"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00007"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/126.2.310"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021704"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04056-3"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207260-00020"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13802-0"},{"key":"e_1_2_1_18_1","unstructured":"National Cholesterol Education Program.2005.Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Available athttp:\/\/www.nhlbi.nih.gov\/guidelines\/cholesterol\/atp3_rpt.htm. Accessed May 5."},{"key":"e_1_2_1_19_1","first-page":"32","article-title":"Effects of sex and race on lipodystrophy pathogenesis","volume":"6","author":"Nolan D","year":"2001","journal-title":"J HIV Ther"},{"key":"e_1_2_1_20_1","first-page":"55","article-title":"Sex differences in adverse reactions to antiretroviral drugs","volume":"11","author":"Ofotokun I","year":"2003","journal-title":"Top HIV Med"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00008"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200202011-00005"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/339866"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342020-00001"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/317477"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.00057.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/324088","article-title":"Sex differences in nevirapine rash","volume":"33","author":"Wong KH","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.20676","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.20676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T21:57:44Z","timestamp":1696629464000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.20676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,17]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1002\/jmv.20676"],"URL":"https:\/\/doi.org\/10.1002\/jmv.20676","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,17]]}}}